Ybrain

Established in 2013 in South Korea, Ybrain develops medical devices that measure, and cure neuropsychiatric illness based on neuroscience. The company provides wearable devices based on tDCS that cure Major Depressive Disorder (MDD) and other psychiatric illnesses with its digital platform. Led by a diverse group of experts in neuroscience, software, and electronic engineering, Ybrain aims to offer accessible mental health treatment to everyone through electroceutical CVS.